Filter by
- (-) Niger (10)
- Algeria (2)
- Angola (2)
- Benin (2)
- Botswana (3)
- Burkina Faso (4)
- Burundi (6)
- Cabo Verde (4)
- Cameroon (2)
- Central African Republic (1)
- Chad (2)
- Cote d'Ivoire (1)
- Democratic Republic of the Congo (4)
- Equatorial Guinea (2)
- Eritrea (1)
- Eswatini (3)
- Ethiopia (7)
- Gabon (1)
- Gambia (3)
- Ghana (3)
- Guinea (4)
- Guinea-Bissau (1)
- Kenya (5)
- Lesotho (1)
- Liberia (1)
- Malawi (1)
- Mali (2)
- Mauritania (1)
- Mauritius (4)
- Mozambique (9)
- Namibia (3)
- Nigeria (3)
- Rwanda (5)
- Sao Tome and Principe (1)
- Senegal (3)
- Seychelles (1)
- Sierra Leone (3)
- South Africa (1)
- South Sudan (2)
- Uganda (4)
- United Republic of Tanzania (4)
- Zambia (1)
- Zimbabwe (2)
- 3732 (0)
- Health and care workforce (8)
- Health facilities, service delivery (1)
- Health Information Systems (5)
- Health Insurance, Social Protection (8)
- (-) Health products (10)
- Institutions and mandate (5)
- Protection of specific groups (6)
- Public Health (2)
- 3806 (0)
- Specific health area or disease (8)
Décret No 2022-915/PRN/MSP/P/AS du 30 novembre 2022, portant approbation des statuts de l'Agence Nigérienne de Règlementation du secteur Pharmaceutique
The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.
Décret No 2021-279/PRN/MSP/O/AS du 29 avril 2021, adoptant la Politique Pharmaceutique Nationale
The Decree adopts the national pharmaceutical policy. This policy sets out and prioritizes the medium- and long-term goals set by the State for the pharmaceutical sector, and defines the main strategies for achieving them. It provides a framework within which pharmaceutical sector activities are coordinated. It covers both the public and private sectors, and involves all the main players in the pharmaceutical sector. It is an integral part of national health policy.
Règlement No 04/2020/CM/UEMOA relatif aux procédures d’homologation des produits pharmaceutiques à usage humain
The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.
Arrêté No 110 MSP/SG/DGSP/MT portant révision de la Liste Nationale des Médicaments Essentiels
The decree revises Niger's national list of essential medicines.
Arrêté No 0152/MSP/DGSP/DPH/MT, portant création du Comité multisectoriel pour la lutte contre la contrefaçon et la vente illicite des médicaments et autres produits pharmaceutique
The decree creates a multi-sectoral committee to combat counterfeiting and the illicit sale of medicines and other pharmaceutical products, reporting to Niger's Minister of Public Health.
Arrêté No 69/MSP/DGSP/DPHLMT, portant création du Comité d’Experts chargé de l’évaluation technique des dossiers de demande d’homologation des produits pharmaceutiques à usage humain
The decree establishes a Committee of Experts in charge of technical evaluation, whose mission is to carry out the technical evaluation of applications for registration of pharmaceutical products for human use. It also gives an opinion on the quality, safety and efficacy of pharmaceutical products for human use submitted for registration.
Arrêté No 68/MSP/DGSP/DPHLMT, portant création de la Commission Nationale du Médicament (CNM)
The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.
Arrêté No 466/MSP/DGSP/DPHL/MT, portant additif à l’arrêté n° 065/MSP/DGSP/DPHL/MT du 09 février 2009 portant Liste Nationale des Médicaments essentiels (LNME)
The decree revises Niger's national list of essential medicines from 2009
Règlement No 06/2010/CM/UEMOA relatif aux procédures d’homologation des produits pharmaceutiques à usage humain
The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.
Ordonnance No 97-002 du 10 janvier 1997 portant législation pharmaceutique
The Ordinance provides legislation governing pharmacy. The ordinance regulates the classification of medicines, the registration of medicines, the dispensing of medicines, dietary products, cosmetics, the rules for practicing the profession of pharmacist, the dispensing of medicines by doctors and other aspects.